Cargando…

Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review

BACKGROUND AND OBJECTIVE: Although upper tract urothelial carcinoma (UTUC) shares the histological appearance of urinary bladder cancer (UBC), molecular studies suggest that UTUC and UBC represent two distinct disease entities. However, treatment approaches for UTUC are virtually extrapolated from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomiyama, Eisuke, Fujita, Kazutoshi, Hashimoto, Mamoru, Adomi, Shogo, Kawashima, Atsunari, Minami, Takafumi, Yoshimura, Kazuhiro, Uemura, Hirotsugu, Nonomura, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827402/ https://www.ncbi.nlm.nih.gov/pubmed/36632153 http://dx.doi.org/10.21037/tau-22-457

Ejemplares similares

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2022)

Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2020)

Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide
por: Fujmoto, Saizo, et al.
Publicado: (2022)

Fucosylation in Urological Cancers
por: Fujita, Kazutoshi, et al.
Publicado: (2021)

Fragmentation of cell‐free DNA is induced by upper‐tract urothelial carcinoma–associated systemic inflammation
por: Nakano, Kosuke, et al.
Publicado: (2020)

A case of neuroendocrine tumor at the external urethral meatus after total cystectomy
por: Miki, Koji, et al.
Publicado: (2023)

Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer
por: Nishimoto, Mitsuhisa, et al.
Publicado: (2022)

Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patients
por: Hashimoto, Mamoru, et al.
Publicado: (2021)

Sarcopenia and Visceral Obesity are Significantly Related to Severe Storage Symptoms in Geriatric Female Patients
por: Hashimoto, Mamoru, et al.
Publicado: (2021)

Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma
por: Nakano, Kosuke, et al.
Publicado: (2022)

Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy
por: Nagahara, Akira, et al.
Publicado: (2015)

Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution
por: Ujike, Takeshi, et al.
Publicado: (2016)

A novel model to predict positive prostate biopsy based on serum androgen level
por: Ujike, Takeshi, et al.
Publicado: (2017)

STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma
por: Matsuzaki, Kyosuke, et al.
Publicado: (2018)

Reactivation of latent tuberculosis infection induced by cabazitaxel in a patient with prostate cancer: A case report
por: Hashimoto, Mamoru, et al.
Publicado: (2019)

Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma
por: Kawashima, Atsunari, et al.
Publicado: (2018)

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
por: Fujita, Kazutoshi, et al.
Publicado: (2023)

Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study
por: Yamamoto, Akinaru, et al.
Publicado: (2022)

Prognostic significance of serum fucosylated pro-haptoglobin in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors
por: Kato, Taigo, et al.
Publicado: (2023)

MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma
por: Matsuzaki, Kyosuke, et al.
Publicado: (2017)

Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma
por: Kato, Taigo, et al.
Publicado: (2021)

Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
por: Ujike, Takeshi, et al.
Publicado: (2022)

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2019)

EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome
por: Sato, Mototaka, et al.
Publicado: (2013)

Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2017)

Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer
por: Hayashi, Takuji, et al.
Publicado: (2016)

Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer
por: Koh, Yoko, et al.
Publicado: (2020)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer
por: Matsuzaki, Kyosuke, et al.
Publicado: (2021)

Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2022)

MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma
por: Wang, Cong, et al.
Publicado: (2020)

Mutational Landscape and Environmental Effects in Bladder Cancer
por: Hayashi, Takuji, et al.
Publicado: (2020)

NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract
por: Kawahara, Takashi, et al.
Publicado: (2017)

Acotiamide hydrochloride hydrate added to combination treatment with an α-blocker and a cholinergic drug improved the QOL of women with acute urinary retention: case series
por: Sugimoto, Koichi, et al.
Publicado: (2017)

Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis
por: Matsushita, Makoto, et al.
Publicado: (2022)

Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2020)

The gut microbiota associated with high‐Gleason prostate cancer
por: Matsushita, Makoto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ab03ipret7smvlmoubfcpekps8